Average Co-Inventor Count = 2.87
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance, Inc. (20 from 386 patents)
2. Theravance Biopharma R&d Ip, LLC (11 from 262 patents)
3. G.d. Searle & Company (1,323 patents)
31 patents:
1. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease
2. 10844057 - Process for preparing JAK inhibitors and intermediates thereof
3. 10426766 - Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
4. 9949963 - Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
5. 9290491 - Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
6. 9221763 - Process for preparing biphenyl imidazole compounds
7. 9035061 - Process for preparing a biphenyl-2-ylcarbamic acid
8. 8969370 - 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
9. 8969403 - Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
10. 8889882 - Process for preparing biphenyl imidazole compounds
11. 8816091 - Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
12. 8754223 - Crystalline form of a biphenyl compound
13. 8754225 - Process for preparing a biphenyl-2-ylcarbamic acid
14. 8658691 - Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
15. 8541597 - Process for preparing biphenyl imidazole compounds